Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

60%

3 of 5 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT03450070Not ApplicableCompleted

Repeat Insult Patch Test APPENDIX I to HRL Standard Protocol #100

Role: lead

NCT03673059Not ApplicableCompleted

Clinical Trial to Assess the Effects of Topical Lotions on Changes in the Skin Microbiome and Associations With Itch

Role: lead

NCT01319227Not ApplicableUnknown

Periprosthetic Bone Remodeling Around Uncemented Components in Total Hip Arthroplasty

Role: collaborator

NCT01770860Not ApplicableCompleted

A Test of Different Kinds of Bandages on Healing of Wounds

Role: lead

NCT01484067Not ApplicableCompleted

Study of a Cold Sore Patch for the Treatment of Herpes Labialis

Role: lead

NCT01326910Not ApplicableCompleted

Human Testing of an Over-the-Counter (OTC) Cream in Children With Eczema

Role: lead

All 6 trials loaded